NO20043366L - Kortikotropinfrigjorende faktor-2 reseptoragonister - Google Patents

Kortikotropinfrigjorende faktor-2 reseptoragonister

Info

Publication number
NO20043366L
NO20043366L NO20043366A NO20043366A NO20043366L NO 20043366 L NO20043366 L NO 20043366L NO 20043366 A NO20043366 A NO 20043366A NO 20043366 A NO20043366 A NO 20043366A NO 20043366 L NO20043366 L NO 20043366L
Authority
NO
Norway
Prior art keywords
corticotropin
receptor agonists
releasing factor
releasing
factor
Prior art date
Application number
NO20043366A
Other languages
English (en)
Norwegian (no)
Inventor
Adam Wieslaw Mazur
Robert Joseph Isfort
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20043366L publication Critical patent/NO20043366L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20043366A 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister NO20043366L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34911702P 2002-01-16 2002-01-16
US37633702P 2002-04-29 2002-04-29
US38889502P 2002-06-14 2002-06-14
US41198802P 2002-09-19 2002-09-19
PCT/US2003/001461 WO2003062269A2 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists

Publications (1)

Publication Number Publication Date
NO20043366L true NO20043366L (no) 2004-10-06

Family

ID=27617822

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20043371A NO20043371L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043366A NO20043366L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20043371A NO20043371L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Country Status (30)

Country Link
US (7) US6936585B2 (xx)
EP (4) EP1465922B1 (xx)
JP (3) JP4508648B2 (xx)
KR (3) KR100735586B1 (xx)
CN (3) CN100475844C (xx)
AR (3) AR038144A1 (xx)
AT (4) ATE398632T1 (xx)
AU (2) AU2003205197B2 (xx)
BR (3) BR0306838A (xx)
CA (3) CA2470731C (xx)
CY (1) CY1106133T1 (xx)
DE (4) DE60307044T2 (xx)
DK (2) DK1465923T3 (xx)
ES (4) ES2269976T3 (xx)
HK (1) HK1078095A1 (xx)
IL (5) IL162530A0 (xx)
MA (3) MA27590A1 (xx)
MX (3) MXPA04006883A (xx)
MY (1) MY140306A (xx)
NO (3) NO20043371L (xx)
NZ (3) NZ533598A (xx)
PE (3) PE20030849A1 (xx)
PL (3) PL373529A1 (xx)
PT (2) PT1465921E (xx)
RU (1) RU2294333C2 (xx)
SA (3) SA03230564B1 (xx)
SI (1) SI1465921T1 (xx)
TW (3) TW200302278A (xx)
WO (3) WO2003062277A1 (xx)
ZA (1) ZA200404995B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040049009A1 (en) * 2000-09-22 2004-03-11 Klaus Eckart Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US6936585B2 (en) * 2002-01-16 2005-08-30 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
US20100034822A1 (en) * 2005-03-30 2010-02-11 Vega Masignani Haemophilus Influenzae Type B
WO2007090087A2 (en) * 2006-01-27 2007-08-09 Research Development Foundation Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
WO2009033692A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
KR20100059862A (ko) * 2007-09-11 2010-06-04 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드의 용도
MX2011004718A (es) * 2008-11-04 2011-07-28 Janssen Pharmaceutica Nv Péptidos agonistas de crhr2 y usos de éstos.
EP2206726A1 (en) * 2009-01-08 2010-07-14 Universite Joseph Fourier Non-invasive tools for detecting vulnerable atherosclerotic plaques
BR112012010661A2 (pt) * 2009-11-04 2016-11-22 Janssen Pharmaceutica Nv método para tratar insuficiência cardíaca com peptídeos semelhantes à estressecopina
WO2013063046A1 (en) 2011-10-24 2013-05-02 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
WO2013123094A2 (en) * 2012-02-14 2013-08-22 The Regents Of The University Of California Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
JOP20170153A1 (ar) * 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
WO2018075973A2 (en) * 2016-10-20 2018-04-26 Cortene Inc. Methods of treating diseases resulting from a maladapted stress response
CN110755434B (zh) * 2018-07-27 2022-03-15 中国医学科学院药物研究所 化合物palosuran防治骨骼肌萎缩等疾病的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
EP0860501A3 (en) 1994-06-14 1999-05-19 Neurocrine Biosciences, Inc. Corticotropin-releasing factor2 receptors
US5786203A (en) * 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US5663292A (en) * 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5824771A (en) 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
CA2223792A1 (en) 1995-06-13 1997-01-03 The Salk Institute For Biological Studies Urocortin peptides
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
CA2418144C (en) 2000-08-04 2013-06-18 Research Development Foundation Urocortin proteins and uses thereof
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US6936585B2 (en) * 2002-01-16 2005-08-30 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
KR20040082392A (ko) 2004-09-24
DE60318547T2 (de) 2008-12-24
ATE362488T1 (de) 2007-06-15
DE60321730D1 (de) 2008-07-31
SA03230565B1 (ar) 2006-10-31
EP1465923A1 (en) 2004-10-13
MA27591A1 (fr) 2005-11-01
US20030148956A1 (en) 2003-08-07
PL371364A1 (en) 2005-06-13
DK1465921T3 (da) 2006-11-27
SI1465921T1 (sl) 2006-10-31
SA03230564A (ar) 2005-12-03
CA2470656A1 (en) 2003-07-31
DE60307044D1 (de) 2006-09-07
US20060025339A1 (en) 2006-02-02
NZ533599A (en) 2007-03-30
TW200302277A (en) 2003-08-01
WO2003062268A3 (en) 2003-11-27
EP1724283A3 (en) 2007-04-11
DE60313845T2 (de) 2008-01-31
CN1617885A (zh) 2005-05-18
PT1465921E (pt) 2006-12-29
ES2287484T3 (es) 2007-12-16
RU2004124847A (ru) 2005-04-20
AU2003237419B2 (en) 2006-04-13
KR100758857B1 (ko) 2007-09-14
ES2309909T3 (es) 2008-12-16
DE60318547D1 (de) 2008-02-21
ATE334147T1 (de) 2006-08-15
US7608701B2 (en) 2009-10-27
US20030148957A1 (en) 2003-08-07
MA27592A1 (fr) 2005-11-01
MXPA04006883A (es) 2004-12-06
US7462597B2 (en) 2008-12-09
CY1106133T1 (el) 2011-06-08
KR100758858B1 (ko) 2007-09-14
JP4489434B2 (ja) 2010-06-23
TW200302276A (en) 2003-08-01
EP1465921B1 (en) 2006-07-26
ES2299701T3 (es) 2008-06-01
BR0306826A (pt) 2005-09-06
CA2470656C (en) 2011-06-28
PT1465923E (pt) 2007-08-06
SA03230564B1 (ar) 2006-10-31
EP1465922A2 (en) 2004-10-13
MXPA04006885A (es) 2004-12-06
WO2003062269A2 (en) 2003-07-31
JP2005522191A (ja) 2005-07-28
JP4508648B2 (ja) 2010-07-21
US20080004435A1 (en) 2008-01-03
KR100735586B1 (ko) 2007-07-04
US7192923B2 (en) 2007-03-20
CA2470743A1 (en) 2003-07-31
US7632933B2 (en) 2009-12-15
US20030148958A1 (en) 2003-08-07
US20090124793A1 (en) 2009-05-14
EP1465923B1 (en) 2007-05-16
IL197774A0 (en) 2009-12-24
PE20030747A1 (es) 2003-10-23
EP1724283B1 (en) 2008-06-18
NZ533598A (en) 2007-03-30
RU2294333C2 (ru) 2007-02-27
US7897731B2 (en) 2011-03-01
ATE398632T1 (de) 2008-07-15
AR038143A1 (es) 2004-12-29
NO20043396L (no) 2004-10-06
WO2003062277A1 (en) 2003-07-31
JP2005521387A (ja) 2005-07-21
AU2003205197B2 (en) 2006-03-02
KR20040082389A (ko) 2004-09-24
IL162529A0 (en) 2005-11-20
SA03230565A (ar) 2005-12-03
CN1617887A (zh) 2005-05-18
CA2470731A1 (en) 2003-07-31
CN100391972C (zh) 2008-06-04
PE20030974A1 (es) 2003-12-26
US20100197579A1 (en) 2010-08-05
JP2005525101A (ja) 2005-08-25
WO2003062268A2 (en) 2003-07-31
CA2470731C (en) 2011-06-21
IL162530A0 (en) 2005-11-20
KR20040082390A (ko) 2004-09-24
AR038142A1 (es) 2004-12-29
NZ533600A (en) 2007-02-23
TW200302278A (en) 2003-08-01
HK1078095A1 (en) 2006-03-03
IL196384A0 (en) 2011-07-31
MXPA04006884A (es) 2004-12-06
JP4508649B2 (ja) 2010-07-21
ES2269976T3 (es) 2007-04-01
ZA200404995B (en) 2005-06-29
MA27590A1 (fr) 2005-11-01
BR0306878A (pt) 2004-10-26
PL373529A1 (en) 2005-09-05
BR0306838A (pt) 2005-04-05
DE60313845D1 (de) 2007-06-28
DK1465923T3 (da) 2007-07-02
DE60307044T2 (de) 2007-02-15
MY140306A (en) 2009-12-31
EP1465921A2 (en) 2004-10-13
WO2003062269A3 (en) 2003-11-06
CN100475844C (zh) 2009-04-08
NO20043371L (no) 2004-10-06
IL162431A0 (en) 2005-11-20
EP1724283A2 (en) 2006-11-22
AR038144A1 (es) 2004-12-29
PE20030849A1 (es) 2003-12-01
ATE383372T1 (de) 2008-01-15
CA2470743C (en) 2011-12-13
TWI300442B (en) 2008-09-01
US6936585B2 (en) 2005-08-30
EP1465922B1 (en) 2008-01-09
PL373139A1 (en) 2005-08-22
CN1617886A (zh) 2005-05-18
US7192924B2 (en) 2007-03-20

Similar Documents

Publication Publication Date Title
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
ATE388937T1 (de) Agonisten des cannabinoidrezeptors
DE60330392D1 (de) Cb 1 rezeptor inversagonisten
IS7801A (is) Púrín efnasambönd og notkun þeirra sem kannabinóíð viðtaka bindla
NO20034483L (no) Tilkoblingsanordning for omradenett
DE60329184D1 (de) Es netzwerk
ATE557036T1 (de) Ox40 rezeptor bindende agenzien
DE60336314D1 (de) Substituierte indole
DE50307455D1 (de) Einstellsystem
DE60303333D1 (de) Schwenkbare Kameravorrichtung
DE50311534D1 (de) Gewebeband-einrichtung
NO20044046L (no) Substituerte hydroksyetylaminer
ATE317844T1 (de) Adenosine a2a receptor antagonisten
NO20043366L (no) Kortikotropinfrigjorende faktor-2 reseptoragonister
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
DE50302630D1 (de) Verstellantrieb
IS7582A (is) Hraðlosandi lyfjablanda
NO20044373L (no) Azetidinderivater som CCR-3-reseptorantagonister
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DE60324018D1 (de) Agonisten
DE60300310D1 (de) Keilvorrichtung
NO20023047A (no) Kompenseringsanordning
NO20043799L (no) 2-oksasolaminer og deres anvendelse som 5-HT2B reseptor antagonister
DE60325211D1 (de) Lichtstrahlformvorrichtung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application